US drug approvals
70 approvals with a product on the US market
- Dapagliflozin And Saxagliptin Hydrochloride ANDA211537 · approved 6 Apr 2026
- Fidaxomicin ANDA220374 · approved 27 Jan 2026
- Lamotrigine ANDA217100 · approved 8 Jan 2026
- Nilotinib Hydrochloride ANDA218532 · approved 15 Dec 2025
- Pazopanib Hydrochloride ANDA219922 · approved 4 Sep 2025
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.